Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Plasma Therapy Market- By Type (Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), By Source (Autologous, Allogenic), By Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others), By End User (Hospitals & Clinics, Research Institutions), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2020-2027.

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The Global Plasma Therapy market is fuelling the market growth in the wake of a cost-effective and rapid healing process
The global Plasma therapy market has the potential to grow with USD 327.52 million with bolstering CAGR in the forecast period from 2020-2027. The emerging demand for plasma therapy is owing to the outbreak of coronavirus, emerging cases from sports injuries, and people with low immunity are bolstering market share for the global plasma therapy market.
The plasma therapy is helping to save the lives of people fighting with coronavirus. It is mainly through the way of blood transfusion that the antibodies in the blood of the rehabilitated patients are given to critically ill patients to help the patients' immune system fight the new coronavirus.
The effectiveness is reflected in the reduction of viral load to entirely negative, the increase in the proportion of lymphocytes, the rise in blood oxygen saturation, and the improvement of vital signs and symptoms such as body temperature and breathing.
Moreover, through technological innovation, production process upgrades, product quality improvement, and the expansion of new indications, the demand for plasma therapy is bolstering. Also, the combined treatment of ultrasound and platelet-rich plasma has become an original method for the treatment of various diseases in orthopedics.
Type overview in the Global Plasma Therapy Market
Based on the type, the global plasma therapy market categorized into Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin. The leukocyte-rich fibrin type segment accounted for the largest share in the global plasma therapy market. The protein present in leukocyte-rich fibrin help in healing the patient faster. Also, the healing process creates the potential protein cell network that reduces the pain in bones and other tissue post-treatment.
Source overview in the Global Plasma Therapy Market
Based on the source, the global plasma therapy market segmented into Autologous, Allogenic. The autologous source segment is estimated to account for the largest share of the plasma therapy market in the forecast period. It is mainly owing to the rising cases of sports injuries that have occurred that affect the bone and other tissues. With the adoption of plasma therapy, it heals the bones faster, and new treatments are propelling the market share.
Application overview in the Global Plasma Therapy Market
Based on the application, the global plasma therapy market classified into Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others. The dermatology segment is dominating the market share of the global plasma therapy market. The rising demand for facial rejuvenation process increases the cases of cosmetic procedures. Therefore, the dermatology segment is anticipating bolstering the market share for plasma therapy in the global market.
End-Use overview in the Global Plasma Therapy Market
Based on the end-user, the global plasma therapy market bifurcated into Hospitals & Clinics, Research Institutions. The hospitals & clinics segment has dominated the largest share in the global plasma therapy market. It is owing to the rapid growth of population and urbanization, and the emerging need for increasing health facilities and with cost-effective, quick healing therapies.
Region overview in the Global Plasma Therapy Market
Based on geography, the global plasma therapy market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America region is dominating the market share of the global plasma therapy market. It is mainly due to the rising population of the geriatric population, increasing cases of autologous, and emerging number trauma cases are fueling the market demand for the global plasma therapy.
Global Plasma Therapy Market: Competitive Landscape
Companies such as BioLife Plasma Services, Cambryn Biologics LLC, Biotest, CSL Ltd., Grifols International S.A., Kedrion S.p.A. LFB, Bio Products Laboratory Ltd., China Biologic Products, Inc., Octapharma and others are key players in the global plasma therapy market. 

Global Plasma Therapy Market
Report Content
1.	Research Strategic Development
1.1.	Market Modelling
1.2.	Product Analysis
1.3.	Market Trend and Economic Factors Analysis
1.4.	Market Segmental Analysis
1.5.	Geographical Mapping
1.6.	Country Wise Segregation
2.	Research Methodology
2.1.	Identification of Target Market
2.2.	Data Acquisition 
2.3.	Refining of Data/ Data Transformations
2.4.	Data Validation through Primary Techniques
2.5.	Exploratory Data Analysis
2.6.	Graphical Techniques/Analysis
2.7.	Quantitative Techniques/Analysis
2.8.	Visual Result/Presentation 
3.	Executive Summary
4.	Market Insights
4.1.	Economic Factor Analysis 
4.1.1.	Drivers
4.1.2.	Trends
4.1.3.	Opportunities
4.1.4.	Challenges
4.2.	Competitors & Product Analysis
4.3.	Regulatory Framework
4.4.	Company market share analysis, 2019
4.5.	Porter's Five forces analysis
4.6.	New Investment Analysis
4.7.	PESTEL Analysis
5.	Global Plasma Therapy Market Overview
5.1.	Market Size & Forecast, 2016-2027
5.1.1.	Demand
5.1.1.1.	By Value (USD Million)
5.2.	Market Share & Forecast, 2016-2027
5.2.1.	By Type
5.2.1.1.	Pure PRP
5.2.1.2.	Leucocyte-rich PRP
5.2.1.3.	Pure Platelet-rich Fibrin (PRF)
5.2.1.4.	Leukocyte-rich Fibrin (L-PRF)
5.2.2.	By Source
5.2.2.1.	Autologous
5.2.2.2.	Allogenic
5.2.3.	By Application
5.2.3.1.	Orthopaedics
5.2.3.1.1.	Arthritis
5.2.3.1.2.	Chronic Tendinitis
5.2.3.1.3.	Bone Repair & Regeneration	
5.2.3.2.	Dermatology
5.2.3.2.1.	Androgenic Alopecia
5.2.3.2.2.	Plastic Surgery
5.2.3.3.	Dental
5.2.3.4.	Cardiac Muscle Injury
5.2.3.5.	Nerve Injury
5.2.3.6.	Others
5.2.4.	By End-Use
5.2.4.1.	Hospitals & Clinics
5.2.4.2.	Research Institutions
5.2.5.	By Region
5.2.5.1.	Europe
5.2.5.2.	North America
5.2.5.3.	Asia Pacific
5.2.5.4.	South America 
5.2.5.5.	Middle East & Africa 
6.	Europe Plasma Therapy Market Overview
6.1.	Europe Plasma Therapy Market Size & Forecast, 2016-2027
6.1.1.	Demand
6.1.1.1.	By Value (USD Million)
6.2.	Europe Plasma Therapy Market Share & Forecast, 2016-2027
6.2.1.	By Type
6.2.1.1.	Pure PRP
6.2.1.2.	Leucocyte-rich PRP
6.2.1.3.	Pure Platelet-rich Fibrin (PRF)
6.2.1.4.	Leukocyte-rich Fibrin (L-PRF)
6.2.2.	By Source
6.2.2.1.	Autologous
6.2.2.2.	Allogenic
6.2.3.	By Application
6.2.3.1.	Orthopaedics
6.2.3.1.1.	Arthritis
6.2.3.1.2.	Chronic Tendinitis
6.2.3.1.3.	Bone Repair & Regeneration	
6.2.3.2.	Dermatology
6.2.3.2.1.	Androgenic Alopecia
6.2.3.2.2.	Plastic Surgery
6.2.3.3.	Dental
6.2.3.4.	Cardiac Muscle Injury
6.2.3.5.	Nerve Injury
6.2.3.6.	Others
6.2.4.	By End-Use
6.2.4.1.	Hospitals & Clinics
6.2.4.2.	Research Institutions
6.2.5.	By Country
6.2.5.1.	Germany
6.2.5.2.	UK
6.2.5.3.	France
6.2.5.4.	Italy
6.2.5.5.	Rest of Europe
6.2.6.	Company Market Share (Top 3-5)
6.2.7.	Economic Impact Study on Europe Plasma Therapy Market 
7.	North Plasma Therapy Market Overview
7.1.	North America Plasma Therapy Market Size & Forecast, 2016-2027
7.1.1.	Demand
7.1.1.1.	By Value (USD Million)
7.2.	North America Plasma Therapy Market Share & Forecast, 2016-2027
7.2.1.	By Type
7.2.1.1.	Pure PRP
7.2.1.2.	Leucocyte-rich PRP
7.2.1.3.	Pure Platelet-rich Fibrin (PRF)
7.2.1.4.	Leukocyte-rich Fibrin (L-PRF)
7.2.2.	By Source
7.2.2.1.	Autologous
7.2.2.2.	Allogenic
7.2.3.	By Application
7.2.3.1.	Orthopaedics
7.2.3.1.1.	Arthritis
7.2.3.1.2.	Chronic Tendinitis
7.2.3.1.3.	Bone Repair & Regeneration	
7.2.3.2.	Dermatology
7.2.3.2.1.	Androgenic Alopecia
7.2.3.2.2.	Plastic Surgery
7.2.3.3.	Dental
7.2.3.4.	Cardiac Muscle Injury
7.2.3.5.	Nerve Injury
7.2.3.6.	Others
7.2.4.	By End-Use
7.2.4.1.	Hospitals & Clinics
7.2.4.2.	Research Institutions
7.2.5.	By Country
7.2.5.1.	US
7.2.5.2.	Canada
7.2.5.3.	Mexico
7.2.6.	Company Market Share (Top 3-5)
7.2.7.	Economic Impact Study on North America Plasma Therapy Market 
8.	Asia Pacific Plasma Therapy Market Overview
8.1.	Asia Pacific Plasma Therapy Market Size & Forecast, 2016-2027
8.1.1.	Demand
8.1.1.1.	By Value (USD Million)
8.2.	Asia Pacific Plasma Therapy Market Share & Forecast, 2016-2027
8.2.1.	By Type
8.2.1.1.	Pure PRP
8.2.1.2.	Leucocyte-rich PRP
8.2.1.3.	Pure Platelet-rich Fibrin (PRF)
8.2.1.4.	Leukocyte-rich Fibrin (L-PRF)
8.2.2.	By Source
8.2.2.1.	Autologous
8.2.2.2.	Allogenic
8.2.3.	By Application
8.2.3.1.	Orthopaedics
8.2.3.1.1.	Arthritis
8.2.3.1.2.	Chronic Tendinitis
8.2.3.1.3.	Bone Repair & Regeneration	
8.2.3.2.	Dermatology
8.2.3.2.1.	Androgenic Alopecia
8.2.3.2.2.	Plastic Surgery
8.2.3.3.	Dental
8.2.3.4.	Cardiac Muscle Injury
8.2.3.5.	Nerve Injury
8.2.3.6.	Others
8.2.4.	By End-Use
8.2.4.1.	Hospitals & Clinics
8.2.4.2.	Research Institutions
8.2.5.	By Country
8.2.5.1.	China
8.2.5.2.	India
8.2.5.3.	Japan
8.2.5.4.	Australia
8.2.5.5.	Rest of Asia Pacific
8.2.6.	Company Market Share (Top 3-5)
8.2.7.	Economic Impact Study on Asia Pacific Plasma Therapy Market 
9.	South America Plasma Therapy Market Overview
9.1.	South America Plasma Therapy Market Size & Forecast, 2016-2027
9.1.1.	Demand
9.1.1.1.	By Value (USD Million)
9.2.	South America Plasma Therapy Market Share & Forecast, 2016-2027
9.2.1.	By Type
9.2.1.1.	Pure PRP
9.2.1.2.	Leucocyte-rich PRP
9.2.1.3.	Pure Platelet-rich Fibrin (PRF)
9.2.1.4.	Leukocyte-rich Fibrin (L-PRF)
9.2.2.	By Source
9.2.2.1.	Autologous
9.2.2.2.	Allogenic
9.2.3.	By Application
9.2.3.1.	Orthopaedics
9.2.3.1.1.	Arthritis
9.2.3.1.2.	Chronic Tendinitis
9.2.3.1.3.	Bone Repair & Regeneration	
9.2.3.2.	Dermatology
9.2.3.2.1.	Androgenic Alopecia
9.2.3.2.2.	Plastic Surgery
9.2.3.3.	Dental
9.2.3.4.	Cardiac Muscle Injury
9.2.3.5.	Nerve Injury
9.2.3.6.	Others
9.2.4.	By End-Use
9.2.4.1.	Hospitals & Clinics
9.2.4.2.	Research Institutions
9.2.5.	By Country
9.2.5.1.	Brazil
9.2.5.2.	Argentina
9.2.5.3.	Rest of South America
9.2.6.	Company Market Share (Top 3-5)
9.2.7.	Economic Impact Study on South America Plasma Therapy Market
10.	Middle East & Africa Plasma Therapy Market Overview
10.1.	Middle East & Africa Plasma Therapy Market Size & Forecast, 2016-2027
10.1.1.	Demand
10.1.1.1.	By Value (USD Million)
10.2.	Middle East & Africa Plasma Therapy Market Share & Forecast, 2016-2027
10.2.1.	By Type
10.2.1.1.	Pure PRP
10.2.1.2.	Leucocyte-rich PRP
10.2.1.3.	Pure Platelet-rich Fibrin (PRF)
10.2.1.4.	Leukocyte-rich Fibrin (L-PRF)
10.2.2.	By Source
10.2.2.1.	Autologous
10.2.2.2.	Allogenic
10.2.3.	By Application
10.2.3.1.	Orthopaedics
10.2.3.1.1.	Arthritis
10.2.3.1.2.	Chronic Tendinitis
10.2.3.1.3.	Bone Repair & Regeneration	
10.2.3.2.	Dermatology
10.2.3.2.1.	Androgenic Alopecia
10.2.3.2.2.	Plastic Surgery
10.2.3.3.	Dental
10.2.3.4.	Cardiac Muscle Injury
10.2.3.5.	Nerve Injury
10.2.3.6.	Others
10.2.4.	By End-Use
10.2.4.1.	Hospitals & Clinics
10.2.4.2.	Research Institutions
10.2.5.	By Country
10.2.5.1.	Saudi Arabia
10.2.5.2.	UAE
10.2.5.3.	South Africa
10.2.5.4.	Rest of Middle East & Africa
10.2.6.	Company Market Share (Top 3-5)
10.2.7.	Economic Impact Study on Middle East & Africa Plasma Therapy Market
11.	Competitor Analysis
11.1.	Company Description
11.2.	Financial Analysis
11.3.	Key Products
11.4.	Key Management Personnel 
11.5.	Contact Address
11.6.	SWOT Analysis
11.7.	Company Profile
11.7.1.1.	BioLife Plasma Services
11.7.1.2.	Cambryn Biologics LLC
11.7.1.3.	Biotest
11.7.1.4.	CSL Ltd.
11.7.1.5.	Grifols International S.A.
11.7.1.6.	Kedrion S.p.A. LFB
11.7.1.7.	Bio Products Laboratory Ltd.
11.7.1.8.	China Biologic Products, Inc.
11.7.1.9.	 Octapharma 
11.7.1.10.	 Other players

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Cell Therapy Platform Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031...
View More
Cell And Gene Therapy Services Market Size And Share Analysis - Growth Trends And Forecasts (...
View More
PPMO (Peptide-PMO Conjugates) Therapy Market Size And Share Analysis - Growth Trends And Fore...
View More
Hip Pain Therapy Solutions Market Size And Share Analysis - Growth Trends And Forecasts (2024...
View More
Cell Therapy Biomanufacturing Market Size And Share Analysis - Growth Trends And Forecasts (2...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved